AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Spire Healthcare Group PLC

Transaction in Own Shares Dec 2, 2024

5328_rns_2024-12-02_a42b217e-c40d-437a-b67f-9365c9700cc5.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 2686O

Spire Healthcare Group PLC

02 December 2024

2 December 2024

Spire Healthcare Group plc

Transaction in own shares

Spire Healthcare Group plc (the "Company") announces that, in accordance with the terms of its share buyback programme announced on 31 October 2024 (the "Share Buyback Programme") and the authority granted by its shareholders at the Company's 2024 Annual General Meeting held on 9 May 2024, it has purchased the following number of its ordinary shares of 1 pence each ("Shares") on the London Stock Exchange through Numis Securities Limited ("Deutsche Numis"):

Date of purchase: 29 November 2024
Number of Shares purchased: 50,000
Highest price paid per Share (GBp): 234.00
Lowest price paid per Share (GBp): 224.00
Volume weighted average price paid per Share (GBp): 227.9059
Broker: Deutsche Numis
Trading venue: London Stock Exchange

The purchased Shares will be cancelled.

Following the purchase of these Shares, the remaining number of Shares in issue will be 403,114,472. The Company does not hold any Shares in treasury. Therefore, the total number of voting rights in the Company is 403,114,472. This figure may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Deutsche Numis as part of the Share Buyback Programme:

Date of purchase Number of ordinary shares purchased Transaction price

(GBp share)
Time of transaction (UK Time) Transaction reference number Trading venue
29 November 2024 2701 234.00 11:59:55 00072642049TRLO0 XLON
29 November 2024 2677 234.00 11:59:55 00072642050TRLO0 XLON
29 November 2024 1490 234.00 11:59:55 00072642052TRLO0 XLON
29 November 2024 5000 234.00 11:59:55 00072642051TRLO0 XLON
29 November 2024 804 224.00 12:59:06 00072643387TRLO0 XLON
29 November 2024 598 224.00 12:59:06 00072643388TRLO0 XLON
29 November 2024 598 224.00 12:59:06 00072643389TRLO0 XLON
29 November 2024 598 224.00 12:59:06 00072643390TRLO0 XLON
29 November 2024 1497 224.00 12:59:06 00072643391TRLO0 XLON
29 November 2024 2393 224.00 12:59:06 00072643392TRLO0 XLON
29 November 2024 1320 227.00 14:20:19 00072645523TRLO0 XLON
29 November 2024 1160 227.00 14:20:19 00072645522TRLO0 XLON
29 November 2024 2480 226.50 14:20:19 00072645526TRLO0 XLON
29 November 2024 246 227.00 14:20:19 00072645525TRLO0 XLON
29 November 2024 1800 227.00 14:20:19 00072645524TRLO0 XLON
29 November 2024 466 226.50 14:30:42 00072645874TRLO0 XLON
29 November 2024 487 226.50 14:30:42 00072645873TRLO0 XLON
29 November 2024 14 226.50 14:30:42 00072645872TRLO0 XLON
29 November 2024 300 226.50 14:30:42 00072645871TRLO0 XLON
29 November 2024 71 226.50 14:30:42 00072645870TRLO0 XLON
29 November 2024 1120 226.50 14:30:42 00072645869TRLO0 XLON
29 November 2024 2512 226.00 14:31:33 00072645934TRLO0 XLON
29 November 2024 1541 227.00 15:07:48 00072647545TRLO0 XLON
29 November 2024 1160 227.00 15:07:48 00072647544TRLO0 XLON
29 November 2024 983 226.50 15:08:54 00072647655TRLO0 XLON
29 November 2024 809 226.50 15:09:01 00072647657TRLO0 XLON
29 November 2024 436 226.50 15:09:01 00072647658TRLO0 XLON
29 November 2024 2218 225.50 15:27:32 00072648533TRLO0 XLON
29 November 2024 1676 226.50 16:09:22 00072649759TRLO0 XLON
29 November 2024 1030 226.50 16:09:22 00072649758TRLO0 XLON
29 November 2024 2288 226.00 16:09:22 00072649760TRLO0 XLON
29 November 2024 2290 226.00 16:12:03 00072649917TRLO0 XLON
29 November 2024 1725 225.50 16:23:08 00072650337TRLO0 XLON
29 November 2024 250 226.50 16:27:55 00072650675TRLO0 XLON
29 November 2024 500 226.50 16:27:55 00072650674TRLO0 XLON
29 November 2024 855 227.00 16:28:22 00072650719TRLO0 XLON
29 November 2024 80 227.00 16:28:26 00072650738TRLO0 XLON
29 November 2024 308 227.00 16:28:26 00072650737TRLO0 XLON
29 November 2024 422 227.00 16:28:26 00072650736TRLO0 XLON
29 November 2024 1097 227.00 16:28:31 00072650742TRLO0 XLON

This announcement will also be available on the Company's website at:

https://investors.spirehealthcare.com/news/regulatory-news/

Enquiries:

Spire Healthcare
Harbant Samra, CFO +44 (0)7881 672 365
Instinctif Partners
Julian Walker +44 (0)7825 189 696

Registered Office and Head Office:

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

About Spire Healthcare

Spire Healthcare is a leading independent healthcare group in the United Kingdom, running 38 hospitals and over 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 800 corporate clients.

Working in partnership with over 8,600 experienced consultants, Spire Healthcare delivered tailored, personalised care to over 1 million inpatients, outpatients and daycase patients, and occupational health programme clients, in 2023, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. It also delivers a range of private and NHS mental health, musculoskeletal and dermatological services under the Vita Health Group brand.

Spire Healthcare's well-located and scalable hospitals have delivered successful and award-winning outcomes, positioning the group well with patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI') providers. 98% of Spire Healthcare's inspected locations are rated 'Good', 'Outstanding' or the equivalent by health inspectors in England, Wales and Scotland.

Spire Healthcare is listed on the London Stock Exchange and is a member of the FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSVKLFLZFLBFBQ

Talk to a Data Expert

Have a question? We'll get back to you promptly.